July 2024
1. SERMET-GAUDELUS I, Benaboud S, Bui S, Bihouee T, et al
   Behavioural and sleep issues after initiation of elexacaftor-tezacaftor-ivacaftor in preschool-age children with cystic fibrosis.
   Lancet. 2024;404:117-120.
   

   >> Share

   
   October 2023
2. CHEUNG JMY, Scott H, Muench A, Riemann D, et al
   Deprescribing benzodiazepine receptor agonists for insomnia in older adults - Authors' reply.
   Lancet. 2023;402:1422.
   

   >> Share

   
   
3. CHRISTIAENS A, Aubert CE, Wichniak A, Casanovas AS, et al
   Deprescribing benzodiazepine receptor agonists for insomnia in older adults.
   Lancet. 2023;402:1421-1422.
   

   >> Share

   
   
4. KOVOOR J
   Excessive daytime sleepiness in primary care.
   Lancet. 2023;402:1420.
   

   >> Share

   
   
5. PEREZ-CARBONELL L, Mignot E, Leschziner G, Dauvilliers Y, et al
   Excessive daytime sleepiness in primary care - Authors' reply.
   Lancet. 2023;402:1420-1421.
   

   >> Share

   
   September 2023
6. VAN STRATEN A, van Trigt S, Lancee J
   How to boost implementation for insomnia treatment in primary care?
   Lancet. 2023;402:940-941.
   

   >> Share

   
   
7. KYLE SD, Siriwardena AN, Espie CA, Yang Y, et al
   Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial.
   Lancet. 2023;402:975-987.
   

   >> Share

   
   June 2023
8. HUANG C, Huang L, Wang Y, Li X, et al
   6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
   Lancet. 2023 Jun 12:S0140-6736(23)00810-3. doi: 10.1016/S0140-6736(23)00810.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share